METTL3介导的HDGF mRNA m6A修饰促进胃癌进展并具有预后意义
该研究在人胃癌队列中评估METTL3表达的预后价值,并在体内外探究其生物学作用与机制。结果显示胃癌中m6A RNA水平显著升高,METTL3为主要调节因子且高表达与不良预后相关,是多因素Cox回归中的独立预后因素。机制上METTL3上调促进胃癌增殖和肝转移,通过m6A修饰稳定HDGF mRNA,分泌型HDGF促进肿瘤血管生成、核内HDGF激活GLUT4和ENO2增加糖酵解。
要点
- 胃癌中m6A RNA水平显著升高,METTL3是其主要调节因子。
- METTL3高表达与胃癌不良预后相关,为独立预后因素。
- METTL3通过m6A修饰稳定HDGF mRNA促进血管生成和糖酵解。
核心结论
- METTL3表达升高通过促进肿瘤血管生成和糖酵解推动胃癌进展,是潜在预后生物标志物和治疗靶点。
研究设计与样本
- 研究采用组织芯片和免疫组化染色在人胃癌队列中评估METTL3表达的预后价值。
- 在体外和体内实验中确定METTL3在胃癌肿瘤生长和肝转移中的生物学作用及机制。
主要发现
- 胃癌中m6A RNA水平显著升高,METTL3是参与丰富m6A RNA修饰的主要调节因子。
- METTL3在胃癌组织中表达显著升高并与不良预后相关。
- 多因素Cox回归分析显示METTL3表达是人胃癌患者的独立预后因素和有效预测因子。
- METTL3过表达在体外和体内促进胃癌增殖和肝转移。
- P300介导的METTL3启动子H3K27乙酰化激活诱导METTL3转录,刺激HDGF mRNA的m6A修饰,m6A阅读蛋白IGF2BP3直接识别并结合HDGF mRNA上的m6A位点增强其稳定性。
临床怎么用
- METTL3表达可作为人胃癌的潜在预后生物标志物用于风险分层。
- METTL3及其下游HDGF相关通路是胃癌的潜在治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: N6-methyladenosine (m6A) RNA methylation and its associated methyltransferase METTL3 are involved in tumour initiation and progression via the regulation of RNA function. This study explored the biological function and clinical significance of METTL3 in gastric cancer (GC). DESIGN: The prognostic value of METTL3 expression was evaluated using tissue microarray and immunohistochemical staining analyses in a human GC cohort. The biological role and mechanism of METTL3 in GC tumour growth and liver metastasis were determined in vitro and in vivo. RESULTS: The level of m6A RNA was significantly increased in GC, and METTL3 was the main regulator involved in the abundant m6A RNA modification. METTL3 expression was significantly elevated in GC tissues and associated with poor prognosis. Multivariate Cox regression analysis revealed that METTL3 expression was an independent prognostic factor and effective predictor in human patients with GC. Moreover, METTL3 overexpression promoted GC proliferation and liver metastasis in vitro and in vivo. Mechanistically, P300-mediated H3K27 acetylation activation in the promoter of METTL3 induced METTL3 transcription, which stimulated m6A modification of HDGF mRNA, and the m6A reader IGF2BP3 then directly recognised and bound to the m6A site on HDGF mRNA and enhanced HDGF mRNA stability. Secreted HDGF promoted tumour angiogenesis, while nuclear HDGF activated GLUT4 and ENO2 expression, followed by an increase in glycolysis in GC cells, which was correlated with subsequent tumour growth and liver metastasis. CONCLUSIONS: Elevated METTL3 expression promotes tumour angiogenesis and glycolysis in GC, indicating that METTL3 expression is a potential prognostic biomarker and therapeutic target for human GC.
引用
- Wang Q, Chen C, Ding Q, et al. METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance. Gut. 2019. PMID: 31582403. doi:10.1136/gutjnl-2019-319639
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。